Your browser doesn't support javascript.
loading
Efficacy and safety of danoprevir plus sofosbuvir in GT 1, 2, 3, or 6 chronic hepatitis C patients with or without cirrhosis in China.
Pan, Shufang; Feng, Kai; Huang, Ping; Zeng, Yingfu; Ke, Liu; Yang, Xiaodong; Liu, Jing; Lin, Chaoshuang.
Afiliación
  • Pan S; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University.
  • Feng K; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University.
  • Huang P; Department of Infectious Diseases, The People's Hospital of Lianjiang, Guangdong Province.
  • Zeng Y; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University.
  • Ke L; Liuzhou People's Hospital, Liuzhou, Guangxi.
  • Yang X; Kunming Third People's Hospital, Kunming, China.
  • Liu J; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University.
  • Lin C; Department of Infectious Diseases, The Third Affiliated Hospital of Sun Yat-Sen University.
Medicine (Baltimore) ; 100(24): e26312, 2021 Jun 18.
Article en En | MEDLINE | ID: mdl-34128871

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / Ribavirina / Sulfonamidas / Prolina / Hepacivirus / Hepatitis C Crónica / Ciclopropanos / Lactamas Macrocíclicas / Isoindoles / Sofosbuvir Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Medicine (Baltimore) Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Antivirales / Ribavirina / Sulfonamidas / Prolina / Hepacivirus / Hepatitis C Crónica / Ciclopropanos / Lactamas Macrocíclicas / Isoindoles / Sofosbuvir Tipo de estudio: Clinical_trials / Observational_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged País/Región como asunto: Asia Idioma: En Revista: Medicine (Baltimore) Año: 2021 Tipo del documento: Article